From the Journals

First antidepressant use not tied to first abortion

View on the News

Nonjudgmental support critical

The study by Julia R. Steinberg, PhD, and her associates adds to the body of evidence showing that abortion is not associated with an increased risk of mental disorders, wrote Nada L. Stotland, MD, and Angela D. Shrestha, MD, in an editorial accompanying the article in JAMA Psychiatry (2018 May 30. doi: 10.1001/jamapsychiatry.2018.0838).

“The authors report that, compared with women who had not had an abortion, women who had a first abortion had a higher risk of first-time antidepressant prescription,” Dr. Stotland and Dr. Shrestha wrote. “However, the risk of first-time antidepressant prescription was similar to the year before and after an abortion. Giving birth was associated with a lower likelihood of a prescription, but this likelihood rose after childbirth and continued to rise for 5 years after delivery.”

Dr. Stotland and Dr. Shrestha also praised the methodology used by Dr. Steinberg and her associates, particularly the decision to make pregnant women who choose to remain pregnant a control group. However, women who opt to continue their pregnancies are more likely to have supportive and healthy circumstances that influence them to make that decision, Dr. Stotland and Dr. Shrestha said.

The decision to have an abortion is fraught with complexities. Ultimately, clinicians must recognize that abortions are indeed significant events for women, and offer them both accurate information and nonjudgmental support, they wrote.

Dr. Stotland is affiliated with Rush University in Chicago and the University of Illinois at Chicago. Dr. Shrestha also is affiliated with the University of Illinois at Chicago. They reported no conflicts of interest.


 

FROM JAMA PSYCHIATRY

Women who have had an abortion are more likely to use antidepressants than women who have not had an abortion, but new research suggests that this association is a result of differences in risk factors for depression.

“Thus, policies based on the notion that abortion harms women’s mental health may be misinformed,” wrote Julia R. Steinberg, PhD, and her coauthors in JAMA Psychiatry.

Dr. Steinberg and her coauthors looked at a cohort of Danish women, intending to examine the association between first-time antidepressant use and either first-trimester abortion or first childbirth. “One shortcoming of many studies in the field is their reliance on self-report of both abortion and mental health problems, which is subject to both faulty memory and social desirability in reporting,” wrote Dr. Steinberg of the University of Maryland, College Park, and her coauthors. Using data on abortion, childbirth, and antidepressants from the Danish population registries, which were collected over time, avoided that limitation.

Of the 396,397 women, 17,294 (4.4%) had at least one first-trimester abortion and no children, 72,052 (18.2%) had no abortions and at least one childbirth, 13,540 (3.4%) had at least one abortion and at least one childbirth, and 293,511 (74.1%) had neither an abortion nor a childbirth.

Of 30,834 women who had an abortion and filled at least one antidepressant prescription, 5,705 (18.5%) initiated antidepressant use after a first abortion. Of 85,592 women who gave birth and filled at least one antidepressant prescription, 10,825 (12.7%) initiated antidepressant use after a first childbirth.

The researchers were limited to 2-month increments of incidence rates for patient confidentiality reasons.

While women who had an abortion were more likely than women who had not to obtain an antidepressant prescription, “the rate of new antidepressant use was the same in the year before and year after and decreased with increasing time after the abortion,” the researchers wrote. “Contrary to previous claims that abortion has long-term adverse effects, the risk of depression decreased as more time elapsed after the abortion.”

Pages

Recommended Reading

Adolescent suicidal ideation and attempts are on the rise
MDedge Internal Medicine
ECT cost effective in treatment-resistant depression
MDedge Internal Medicine
Cognitive-behavioral therapy modified for maximum efficacy in the elderly
MDedge Internal Medicine
Two more and counting: Suicide in medical trainees
MDedge Internal Medicine
Heart rate variability may be risk factor for depression, not a consequence
MDedge Internal Medicine
Simple postural exercises may reduce depressive symptoms
MDedge Internal Medicine
Palliative care may reduce suicide among lung cancer patients
MDedge Internal Medicine
Antidepressant use linked to increased weight gain
MDedge Internal Medicine
Americans back from captivity need decompression period
MDedge Internal Medicine
Esketamine nasal spray prevails in two phase 3 trials
MDedge Internal Medicine